Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 3.78 is 100% below its estimated 5-year average of 1221.05, near the low end of its estimated 5-year range (3.75–10393.28).
As of 2026-10-06T13:42:36.412Z. 23.65% below its estimated 12-month average of 4.95.
Calculation as of: 2026-10-06T13:42:36.412Z.
Quote observation: 2026-10-06T13:40:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea8f5c362e28cab1379660d94c14b865908cd29a247cab29e6d5b71901c6c862
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
3.78
PS RATIO AVG TTM
4.95
PS RATIO AVG 3Y
1330.17
PS RATIO AVG 5Y
1221.05
PS RATIO AVG 10Y
589.35
PS RATIO AVG 15Y
371.40
PS RATIO AVG 20Y
261.09
CURRENT VS TTM AVG
-23.65%
CURRENT VS 3Y AVG
-99.72%
CURRENT VS 5Y AVG
-99.69%
CURRENT VS 10Y AVG
-99.36%
CURRENT VS 15Y AVG
-98.98%
CURRENT VS 20Y AVG
-98.55%
SECTOR MEDIAN · HEALTHCARE
4.13
median of 365 covered companies
CURRENT VS SECTOR MEDIAN
-8.47%
vs the sector median at left
Market Cap
$768.46M
PS Ratio
18.53
TTM Avg
12.05
3Y Avg
176.43
5Y Avg
968.45
Market Cap
$751.69M
PS Ratio
12740.48
TTM Avg
4690.70
3Y Avg
1617.75
5Y Avg
973.20
Market Cap
$761.28M
PS Ratio
N/A
TTM Avg
1076.18
3Y Avg
1003.10
5Y Avg
1003.10
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $773.03M | 3.78 | 4.95 | 1330.17 | 1221.05 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $790.35M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $768.46M | 18.53 | 12.05 | 176.43 | 968.45 |
| Design Therapeutics, Inc. (DSGN)vs › | $766.35M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $751.69M | 12740.48 | 4690.70 | 1617.75 | 973.20 |
| AdaptHealth Corp. (AHCO)vs › | $786.39M | 0.26 | 0.48 | 0.44 | 0.69 |
| Candel Therapeutics, Inc. (CADL)vs › | $761.28M | N/A | 1076.18 | 1003.10 | 1003.10 |
| Cytek Biosciences, Inc. (CTKB)vs › | $794.39M | 3.84 | 2.95 | 3.49 | 6.67 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $804.39M | 6.74 | 6.23 | 9.08 | 36.05 |
| InMode Ltd. (INMD)vs › | $813.07M | 2.17 | 2.45 | 3.11 | 6.00 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $47,227,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $48,015,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $51,837,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $57,480,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $204,559,000 |
Current P/S: $773,032,774 market capitalization ÷ $204,559,000 TTM revenue = 3.78x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:40:11.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 3.78, P/S is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 20-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 20-year low
3.75
median
239.84
estimated 20-year high
10393.28
P/S Ratio
3.78
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 3.97 |
| 2026-10-02 | 3.93 |
| 2026-10-01 | 3.97 |
| 2026-09-30 | 4.03 |
| 2026-09-29 | 4.07 |
| 2026-09-28 | 4.10 |
| 2026-09-25 | 4.13 |
| 2026-09-24 | 4.13 |
| 2026-09-23 | 4.07 |
| 2026-09-22 | 4.30 |
| 2026-09-21 | 4.26 |
| 2026-09-18 | 4.26 |
| 2026-09-17 | 4.33 |
| 2026-09-16 | 4.23 |
| 2026-09-15 | 4.30 |
| 2026-09-14 | 4.49 |
| 2026-09-11 | 4.43 |
| 2026-09-10 | 4.49 |
| 2026-09-09 | 4.59 |
| 2026-09-08 | 4.95 |
| 2026-09-04 | 5.15 |
| 2026-09-03 | 4.95 |
| 2026-09-02 | 5.21 |
| 2026-09-01 | 4.85 |
| 2026-08-31 | 4.89 |
| 2026-08-28 | 4.95 |
| 2026-08-27 | 5.02 |
| 2026-08-26 | 5.02 |
| 2026-08-25 | 5.08 |
| 2026-08-24 | 4.98 |
| 2026-08-21 | 4.98 |
| 2026-08-20 | 5.08 |
| 2026-08-19 | 5.21 |
| 2026-08-18 | 5.02 |
| 2026-08-17 | 5.02 |
| 2026-08-14 | 4.82 |
| 2026-08-13 | 5.05 |
| 2026-08-12 | 5.15 |
| 2026-08-11 | 5.34 |
| 2026-08-10 | 4.85 |
| 2026-08-07 | 4.85 |
| 2026-08-06 | 5.15 |
| 2026-08-05 | 5.56 |
| 2026-08-04 | 4.57 |
| 2026-08-03 | 4.37 |
| 2026-07-31 | 4.40 |
| 2026-07-30 | 4.57 |
| 2026-07-29 | 4.78 |
| 2026-07-28 | 4.95 |
| 2026-07-27 | 5.05 |
| 2026-07-24 | 4.85 |
| 2026-07-23 | 4.95 |
| 2026-07-22 | 4.81 |
| 2026-07-21 | 4.91 |
| 2026-07-20 | 4.91 |
| 2026-07-17 | 4.91 |
| 2026-07-16 | 4.85 |
| 2026-07-15 | 4.85 |
| 2026-07-14 | 4.71 |
| 2026-07-13 | 4.85 |
| 2026-07-10 | 5.12 |
| 2026-07-09 | 5.32 |
| 2026-07-08 | 5.32 |
| 2026-07-07 | 5.09 |
| 2026-07-06 | 4.91 |
| 2026-07-02 | 4.64 |
| 2026-07-01 | 4.33 |
| 2026-06-30 | 4.37 |
| 2026-06-29 | 4.44 |
| 2026-06-26 | 4.51 |
| 2026-06-25 | 4.68 |
| 2026-06-24 | 4.74 |
| 2026-06-23 | 4.61 |
| 2026-06-22 | 4.57 |
| 2026-06-18 | 4.30 |
| 2026-06-17 | 4.20 |
| 2026-06-16 | 4.03 |
| 2026-06-15 | 3.93 |
| 2026-06-12 | 3.93 |
| 2026-06-11 | 3.89 |
| 2026-06-10 | 3.75 |
| 2026-06-09 | 3.82 |
| 2026-06-08 | 3.86 |
| 2026-06-05 | 3.99 |
| 2026-06-04 | 4.13 |
| 2026-06-03 | 3.96 |
| 2026-06-02 | 3.99 |
| 2026-06-01 | 4.13 |
| 2026-05-29 | 4.27 |
| 2026-05-28 | 4.27 |
| 2026-05-27 | 4.30 |
| 2026-05-26 | 4.37 |
| 2026-05-22 | 4.37 |
| 2026-05-21 | 4.30 |
| 2026-05-20 | 4.30 |
| 2026-05-19 | 4.16 |
| 2026-05-18 | 4.20 |
| 2026-05-15 | 4.40 |
| 2026-05-14 | 4.78 |
| 2026-05-13 | 4.81 |
| 2026-05-12 | 4.78 |
| 2026-05-11 | 4.74 |
| 2026-05-08 | 4.74 |
| 2026-05-07 | 4.98 |
| 2026-05-06 | 5.73 |
| 2026-05-05 | 5.99 |
| 2026-05-04 | 5.70 |
| 2026-05-01 | 5.73 |
| 2026-04-30 | 5.59 |
| 2026-04-29 | 5.48 |
| 2026-04-28 | 5.48 |
| 2026-04-27 | 5.55 |
| 2026-04-24 | 5.44 |
| 2026-04-23 | 5.44 |
| 2026-04-22 | 5.62 |
| 2026-04-21 | 5.44 |
| 2026-04-20 | 5.66 |
| 2026-04-17 | 6.10 |
| 2026-04-16 | 6.13 |
| 2026-04-15 | 6.13 |
| 2026-04-14 | 6.42 |
| 2026-04-13 | 6.28 |
| 2026-04-10 | 6.06 |
| 2026-04-09 | 6.39 |
| 2026-04-08 | 6.20 |
| 2026-04-07 | 6.31 |
| 2026-04-06 | 6.35 |
| 2026-04-02 | 6.02 |
| 2026-04-01 | 6.02 |
| 2026-03-31 | 5.41 |
| 2026-03-30 | 5.12 |
| 2026-03-27 | 5.08 |
| 2026-03-26 | 5.59 |
| 2026-03-25 | 5.70 |
| 2026-03-24 | 5.48 |
| 2026-03-23 | 5.59 |
| 2026-03-20 | 5.30 |
| 2026-03-19 | 5.62 |
| 2026-03-18 | 5.62 |
| 2026-03-17 | 5.88 |
| 2026-03-16 | 5.99 |
| 2026-03-13 | 5.73 |
| 2026-03-12 | 5.81 |
| 2026-03-11 | 6.02 |
| 2026-03-10 | 5.91 |
| 2026-03-09 | 5.88 |
| 2026-03-06 | 5.55 |
| 2026-03-05 | 5.15 |
| 2026-03-04 | 5.33 |
| 2026-03-03 | 5.22 |
| 2026-03-02 | 5.64 |
| 2026-02-27 | 6.11 |
| 2026-02-26 | 6.00 |
| 2026-02-25 | 6.26 |
| 2026-02-24 | 7.09 |
| 2026-02-23 | 6.44 |
| 2026-02-20 | 6.84 |
| 2026-02-19 | 6.98 |
| 2026-02-18 | 7.06 |
| 2026-02-17 | 6.55 |
| 2026-02-13 | 6.00 |
| 2026-02-12 | 5.93 |
| 2026-02-11 | 5.86 |
| 2026-02-10 | 5.89 |
| 2026-02-09 | 5.86 |
| 2026-02-06 | 5.57 |
| 2026-02-05 | 5.31 |
| 2026-02-04 | 5.35 |
| 2026-02-03 | 5.49 |
| 2026-02-02 | 5.60 |
| 2026-01-30 | 4.98 |
| 2026-01-29 | 4.98 |
| 2026-01-28 | 4.84 |
| 2026-01-27 | 5.02 |
| 2026-01-26 | 4.98 |
| 2026-01-23 | 5.02 |
| 2026-01-22 | 5.13 |
| 2026-01-21 | 4.87 |
| 2026-01-20 | 4.73 |
| 2026-01-16 | 4.76 |
| 2026-01-15 | 4.73 |
| 2026-01-14 | 4.91 |
| 2026-01-13 | 4.76 |
| 2026-01-12 | 5.20 |
| 2026-01-09 | 4.87 |
| 2026-01-08 | 4.98 |
| 2026-01-07 | 4.98 |
| 2026-01-06 | 4.80 |
| 2026-01-05 | 4.80 |
| 2026-01-02 | 4.80 |
| 2025-12-31 | 4.80 |
| 2025-12-30 | 4.87 |
| 2025-12-29 | 4.98 |
| 2025-12-26 | 4.98 |
| 2025-12-24 | 5.09 |
| 2025-12-23 | 4.84 |
| 2025-12-22 | 4.91 |
| 2025-12-19 | 4.84 |
| 2025-12-18 | 4.87 |
| 2025-12-17 | 5.09 |
| 2025-12-16 | 4.87 |
| 2025-12-15 | 4.84 |
| 2025-12-12 | 4.95 |
| 2025-12-11 | 5.06 |
| 2025-12-10 | 4.66 |
| 2025-12-09 | 4.47 |
| 2025-12-08 | 4.62 |
| 2025-12-05 | 4.76 |
| 2025-12-04 | 4.62 |
| 2025-12-03 | 4.62 |
| 2025-12-02 | 4.47 |
| 2025-12-01 | 4.33 |
| 2025-11-28 | 4.29 |
| 2025-11-26 | 4.33 |
| 2025-11-25 | 4.22 |
| 2025-11-24 | 4.22 |
| 2025-11-21 | 4.07 |
| 2025-11-20 | 4.00 |
| 2025-11-19 | 3.93 |
| 2025-11-18 | 4.04 |
| 2025-11-17 | 4.11 |
| 2025-11-14 | 4.07 |
| 2025-11-13 | 4.18 |
| 2025-11-12 | 4.51 |
| 2025-11-11 | 4.55 |
| 2025-11-10 | 4.22 |
| 2025-11-07 | 4.33 |
| 2025-11-06 | 4.38 |
| 2025-11-05 | 4.42 |
| 2025-11-04 | 4.66 |
| 2025-11-03 | 4.86 |
| 2025-10-31 | 5.10 |
| 2025-10-30 | 5.02 |
| 2025-10-29 | 4.98 |
| 2025-10-28 | 5.19 |
| 2025-10-27 | 5.19 |
| 2025-10-24 | 5.02 |
| 2025-10-23 | 4.94 |
| 2025-10-22 | 5.02 |
| 2025-10-21 | 5.14 |
| 2025-10-20 | 5.14 |
| 2025-10-17 | 4.86 |
| 2025-10-16 | 4.98 |
| 2025-10-15 | 5.19 |
| 2025-10-14 | 5.02 |
| 2025-10-13 | 5.14 |
| 2025-10-10 | 5.31 |
| 2025-10-09 | 5.63 |
| 2025-10-08 | 5.59 |
| 2025-10-07 | 5.23 |
| 2025-10-06 | 5.19 |
| 2025-10-03 | 5.47 |
| 2025-10-02 | 5.59 |
| 2025-10-01 | 5.71 |
| 2025-09-30 | 5.55 |
| 2025-09-29 | 5.31 |
| 2025-09-26 | 5.23 |
| 2025-09-25 | 5.14 |
| 2025-09-24 | 5.39 |
| 2025-09-23 | 5.43 |
Showing the most recent 260 of 4,918 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
